Introduction to the Cancer Trials Centre
The Cancer Research UK and UCL Cancer Trials Centre is a research department within UCL Cancer Institute and is part of the Cancer Research UK Centre at UCL.
UCL/ UCL Hospitals is a national Biomedical Research Centre and cancer is a key theme of the Centre which in association with UCL Partners is one of the UK’s Academic Health Science Centres.
UCL is one of the national Experimental Cancer Medicine Centres and UCL and UCL Hospitals has a dedicated Clinical Research Facility for early phase trials.
The CTC was formed in 1997 through the amalgamation of three Cancer Research UK (formerly Cancer Research Campaign) clinical trials groups: two existing groups at UCL - the CRC Lung Group/London Lung Cancer Group and the BNLI (British National Lymphoma Investigation)/CRC Lymphoma Group - were joined by a CRC trials group based at King College London.
Over the last 15 years the CTC has grown to be one of the largest cancer trials centres in the UK. It has more than 80 staff and is one of the 9 accredited clinical trials units of the National Cancer Research Institute (NCRI) and one of the UKCRC registered Clinical Trials Units. The CTC has a well-developed educational and training programme for its staff, local researchers and national groups.
NHS green light for new ovarian cancer drug
Olaparib, also known as Lynparza, is first medicine for ovarian cancer to be made available via the NHS for over 10 years
More information can be found here